Search For "drug eluting balloon"
"Revolutionizing Heart Care & Empowering Patients:" Sirolimus-Driven Ballo
Updated : 6 months, 1 week ago IST
San Francisco [US], November 19: In a defining chapter for global cardiovascular care, MedAlliance, the Swiss-based innovator behind the patented SELUTION Sirolimus Drug-Eluting Balloon (DEB), continues to transform the landscape of heart disease treatment following its acquisition by Cordis
Read More
Cordis Unveiled Positive Results for Two SELUTION SLR DEB Trials
Updated : 6 months, 2 weeks ago IST
Mumbai (Maharashtra) [India], November 11: Cordis, a global leader in interventional cardiovascular technology, announced the groundbreaking results from the SELUTION DeNovo and SELUTION4ISR trials at Transcatheter Cardiovascular Therapeutics® (TCT®) 2025, the annual scientific symposium of
Read More
Concept Medical Announces Successful SIRONA Trial Results, Demonstrating S
Updated : 1 year, 4 months ago IST
Tampa (Florida) [US], January 7: Concept Medical Inc., a global leader in innovative drug-delivery technology, proudly reports positive outcomes from the SIRONA (Head-to-Head Comparison of SIROlimus versus Paclitaxel Drug-Eluting BallooNAngioplasty in the Femoropopliteal Artery) RCT, which s
Read More
MedAlliance, a Pioneering Medical Device Startup, acquired by Cordis of US
Updated : 2 years, 7 months ago IST
Geneva [Switzerland], October 6: MedAlliance, the visionary Swiss-based medical technology company, is delighted to announce the successful acquisition by Cordis, a transaction valued at USD 1.135 billion (Rs. ~ 10,000 Crores). This union represents a remarkable milestone in the realm of med
Read More
MedAlliance Announces Enrollment of over 1,660 Patients in Landmark SELUTI
Updated : 2 years, 8 months ago IST
Geneva [Switzerland], September 15: MedAlliance has announced enrollment of over 1,660 patients in its ground-breaking SELUTION DeNovo coronary randomized study. Recruitment is now half way towards a planned 3,326 patients. SELUTION DeNovo compares the treatment strategy using a novel siroli
Read More
MedAlliance enrolls first US patient into its third FDA IDE Study: SFA SEL
Updated : 3 years ago IST
Geneva [Switzerland], May 5 (ANI/PRNewswire): The first US patient has been enrolled in the SELUTION4SFA Sirolimus DEB study by Dr Arthur Lee at the Cardiac & Vascular Institute in Florida. This study evaluates SELUTION SLR™ in the treatment of occlusive disease of the superficial
Read More
Over 1,000 patients enrolled in Landmark SELUTION DeNovo Study
Updated : 3 years, 2 months ago IST
Geneva [Switzerland], March 15 (ANI/PRNewswire): MedAlliance has announced enrollment of over 1,000 patients in its ground-breaking SELUTION DeNovo coronary randomized study. Recruitment is now a third of the way towards the target of 3,326 patients. SELUTION DeNovo compares the treatment st
Read More
MedAlliance leads US Sirolimus DEB race: First US Patient enrolled into SE
Updated : 3 years, 4 months ago IST
Geneva [Switzerland], January 26 (ANI/PRNewswire): The first US patient has been enrolled at MedStar Washington Hospital Center in the SELUTION4ISR study evaluating SELUTION SLR™ to support FDA approval. This milestone follows Investigational Device Exemption (IDE) approval in the US i
Read More
First US patient enrolled in SELUTION SLR IDE Peripheral Study
Updated : 3 years, 9 months ago IST
Geneva [Switzerland], August 24 (ANI/PRNewswire): The first US patient has been enrolled in the FDA SELUTION4BTK (Below-the-Knee) clinical trial evaluating SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon. This milestone follows Investigational Device Exemption (IDE) approv
Read More
Kauvery Hospital performs Intravascular ultrasound guided Coronary Laser A
Updated : 3 years, 10 months ago IST
Chennai (Tamil Nadu) [India], July 14 (ANI/NewsVoir): Kauvery Hospital Chennai, a unit of Kauvery Group of Hospitals, a leading multispecialty healthcare chain in Tamil Nadu, today announced a 'First time in India' successful procedure of Coronary Laser Atherectomy followed by the use of a D
Read More
MedAlliance announces completion of enrollment in Japanese SELUTION SLR
Updated : 4 years, 8 months ago IST
Geneva [Switzerland], September 23 (ANI/PRNewswire): MedAlliance, with its Japanese partner MDK Medical, has completed enrollment in the clinical study of its novel Sirolimus Drug Eluting Balloon (DEB), SELUTION SLR™, for the treatment of peripheral arterial disease (PAD).
Read More
MedAlliance announces first patient enrolled in the 3,300 Patient Landmark
Updated : 4 years, 8 months ago IST
Geneva [Switzerland], September 1 (ANI/PRNewswire): MedAlliance is pleased to announce the enrollment of the first patient in the ground-breaking coronary randomized controlled study "SELUTION DeNovo". This study utilizes SELUTION SLR™, a novel sirolimus drug-eluting balloon [DEB], ver
Read More